PVC Granule Compound with High Hardness for Hemodialysis Tubes

Name: PVC Granule Compound with High Hardness for Hemodialysis Tubes
Brand: Jiangsu Kaier High Polymer Materials Co., Ltd
SKU: 2192053572

Jiangsu, ChinaJiangsu Kaier High Polymer Materials Co., Ltd

US$1.23-1.52

1 kg

Sample price:US$1.23/kg.Request sample

Product profile

Customization

Available

Feature

Biodegradable

CAS No.

9002-86-2

Model NO.

DBCT

Formula

(C2h3cl)N

EINECS

618-338-8

Material

Polyvinyl Chloride/PVC

Usage

Specialty Plastics

Plastic Properties After Heated

Thermoplastic Plastics

Plastic Forming Method

Extrusion

Color

Natural Transparent Milky White

Product Name

PVC Compound for Hemodialysis Blood Circuit Tube

Hardness

≥60 ±3A

Tensile Strength

≥13 MPa

Acute Systemic Toxicity

Passed ISO10993-11 Test, GB/T15593-2020

Thermal Stability (180℃ Oil Bath)

≥60 Min

Transport Package

25kg PE Laminated Woven Bag with Inner PE Film

Specification

25kg/bag, Customized Packaging Available

Trademark

Kaier

Origin

Jiangsu, China

HS Code

3904220000

Production Capacity

Annual Output: 12000 Metric Tons Per Year

Company profile

Jiangsu Kaier High Polymer Materials Co., Ltd

Jiangsu, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2010-06-01 CertifiedNearest Port: Shanghai PortAverage Response Time: ≤18h CertifiedTerms of Payment: LC, T/T

AI-Powered supplier vetting

SummaryJiangsu Kaier High Polymer Materials Co., Ltd. is a China-based factory established in 2010, with 56 employees and a 33,155 m² manufacturing site. It reports more than 10 production lines, 6–10 quality-control staff, annual output of 35,000 tons of medical PVC compounds and 7,200,000 medical PVC tubes, and approximately one-month fulfillment in both peak and off-peak periods. The supplier exports mainly to Southeast Asia, the Middle East, Australia, and domestic markets, with exports representing 71%–90% of sales. Its stated capabilities include medical PVC materials, cooperation with universities and medical-plastics R&D institutes, ISO 9001:2008-based quality management, and whole-process after-sales service. However, the supplied information does not establish specific certifications beyond the stated quality-system reference, audited financial strength, detailed customization processes, or a sufficiently documented customer track record. Two trade records show one transaction each involving a US...

Supplier typeThe supplier is identified as a factory and a limited company in China, operating in Jiangsu. Its stated business activities cover manufacturing-related sectors including health and medicine, chemicals, packaging and printing, and light industry.

After-Sales capabilityThe supplier explicitly states that it provides products through whole-process after-sale services and emphasizes customer-centered service. This is direct evidence of an after-sales service commitment, although service staffing, response times, and formal service procedures are not provided.

R&D capabilityThe company reports launching non-DEHP PVC compounds and maintaining long-term cooperation with universities and medical-plastics R&D institutes. It also states that it focuses on product development to meet customer requirements, providing direct evidence of product-development activity.

Production capacityThe supplier reports more than 10 production lines, 6–10 quality-control staff, a 33,155 m² facility, and output of 35,000 tons of medical PVC compounds plus 7,200,000 medical PVC tubes. It also reports approximately one-month fulfillment during both peak and off-peak seasons, indicating substantial stated capacity and a defined delivery capability.

Client casesThe supplier describes itself as a regular supplier to high-end medical-device and pharmaceutical manufacturers and identifies Littleflower as an exported brand. Two trade records associate it with AMSINO INTERNATIONAL INC. and a US destination, but each record shows only one transaction and does not provide sufficient detail to assess the breadth or depth of its customer portfolio.